About ASH
Scientific Meetings
Publications
Education
Research
Practice
HTN Community Outreach
ASH Foundation Overview
Corporate Members
Related Organizations
Position Papers
Press
FAQs
ASH Home About Hypertension For Proffesionals For Patients HTN Specialist Membership
American Society of Hypertension (ASH) Members Log in
Make text larger
Home » Scientific Meetings » Scientific Awards » ASH Marvin Moser Clinical HTN Award

ASH Marvin Moser Clinical Hypertension Award

ASH announced a new award in 2009, the Marvin Moser Clinical Hypertension Award. The Marvin Moser Clinical Hypertension Award recognizes a qualified Hypertension Clinician for his or her dedication to the treatment and care of hypertensive patients. The award is presented at the ASH Annual Scientific Meeting. The award recipient receives a $5,000 honorarium, given by the Hypertension Education Foundation, as well as complimentary registration to the ASH Annual Scientific Meeting and reimbursement for travel expenses and hotel accommodations for two nights to attend the Annual Meeting. In addition, the award recipient is recognized at the ASH Annual Scientific Meeting during the Awards Plenary Session.

Qualifications

Candidate:

Must have been involved in treating hypertensive patients as a major component of his or her practice experience
Must be currently active in teaching
May have had an active role in developing guidelines and in clinical trials that focus on improving blood pressure control
May be involved in community programs


Application Requirements

Only ASH Members can nominate candidates
Sponsor submission of complete name, address, phone/fax numbers, and e-mail address of nominee
Signed letter of nomination articulating major contributions of nominee to the treatment and care of hypertensive patients
At least one additional supporting letter
Complete curriculum vitae

Please send all nomination materials to:

Ashley Buron
Program Coordinator
American Society of Hypertension, Inc.
45 Main Street, suite #712
Brooklyn, NY 11201
Phone: 212.696.9099
Fax: 347.916.0267
awards@ash-us.org


The American Society of Hypertension is pleased to announce the recipient of the ASH Marvin Moser Clinical Hypertension Award, Stephen C. Textor, MD. This award recognizes a qualified Hypertension Clinician for his or her dedication to the treatment and care of hypertensive patients.

The 2015 Award was presented during the ASH Thirtieth Annual Scientific Meeting during the Awards Session on Monday, May 18, 2015.

2015 Award Recipient

Stephen C. Textor, M.D.​
Consultant, Division of Nephrology and Hypertension, Department of Internal Medicine
Mayo Clinic in Rochester, Minn

Stephen C. Textor, M.D., is a consultant in the Division of Nephrology and Hypertension, Department of Internal Medicine, at Mayo Clinic in Rochester, Minn. Dr. Textor was born in Colorado, and grew up in Minnesota. He attended Stanford University as an undergraduate and the University of California as a Regents’ Scholar for his medical degree. He trained in internal medicine and was Chief Medical Resident at the Boston City Hospital, before pursuing nephrology and hypertension under the direction of Norman Levinsky and Aram Chobanian at Boston University.

His career path includes a Fogarty international research grant in Lausanne, Switzerland during the development of first angiotensin converting enzyme inhibitor, captopril, followed by an appointment to the research division of the Cleveland Clinic with a focus on renovascular hypertension and ischemic nephropathy. Interests in the relationship between hypertension, cancer and transplantation expanded during a five-year tenure at the City of Hope National Medical Center in Los Angeles, before taking a position in the Hypertension Division at Mayo Clinic, Rochester, Minnesota, where he is now Professor of Medicine, Division of Nephrology and Hypertension and an active participant in the Kidney/Pancreas Transplant Program of the von Liebig Transplant Center at Mayo Clinic.

His professional interests focus upon the relationships between blood pressure and the kidney, including renovascular hypertension. In recent years, Dr. Textor emphasized blood pressure assessment and its role in selecting living kidney donors. Working with colleagues in renal physiology and experimental imaging, he has explored the application of functional magnetic resonance imaging to evaluate tissue oxygenation in the kidney. He is the co-principal investigator of a recently opened “first-in-human” clinical trial funded by the NIH studying the use of mesenchymal stem cells to renew kidney function lost through vascular occlusion.